Governance

CEPI is in its start-up phase.

During this, our activity is being coordinated by an Interim Secretariat. This is provided by the Norwegian government, with close support from the:

  • Government of India
  • Wellcome Trust
  • Bill & Melinda Gates Foundation
  • World Economic Forum

Our Interim Chief Executive Officer is John-Arne Røttingen from the Norwegian Institute of Public Health.

The Interim Secretariat is in discussions with many potential government and philanthropic funders, industry partners and other key stakeholders such as regulators, emergency care providers and the World Health Organization.

CEPI is governed by an Interim Board made up of experts from founding partners, industry, governments and non-governmental organisations. It is chaired by Professor K VijayRaghavan, Secretary of the Indian Department of Biotechnology, with Professor Peter Piot, Director of the London School of Hygiene and Tropical Medicine, as vice-chair.

The Board is advised on decisions such as prioritising pathogens and selecting industrial partners by an Interim Scientific Advisory Committee. This is chaired by Dr Mark Feinberg, CEO of the International AIDS Vaccine Initiative.

A Joint Coordination Group will coordinate the vaccine development efforts of CEPI partners and will link up with other organisations to ensure vaccines reach the populations who need them. The group will be chaired by Dr Margaret Hamburg, foreign secretary at the National Academy of Medicine and former FDA Commissioner. 

Interim Board

  • K. Vijay Raghavan, Secretary, Department of Biotechnology, Ministry of Science and Technology, India (Chair)

  • Peter Piot, Director of the London School of Hygiene and Tropical Medicine (Vice Chair)

  • Adar Poonawalla, CEO and Executive Director, Serum Institute of India

  • Arnaud Bernaert, Head of Global Health and Healthcare Industries, World Economic Forum

  • Christopher Whitty, Chief Scientific Adviser, Department of Health, UK

  • Eduardo de Azeredo Costa, Technical Advisor, Center for International Affairs in Health, Fiocruz

  • Jane Halton, Adjunct Professor, University of Canberra

  • Jeffrey Mphahlele, Vice President, South African Medical Research Council
  • Jeremy Farrar, Director, Wellcome Trust

  • Joachim Klein, Deputy Head of Division Health Research, Federal Ministry of Education and Research, Germany

  • Joanne Liu, International President, Medecins sans Frontieres

  • Julie Gerberding, Executive Vice President, Strategic Communications, Global Public Policy, and Population Health, Merck

  • Moncef Slaoui, Chairman of vaccines, GSK

  • Nima Farzan, President and CEO, PaxVax Inc.

  • Ruxandra Draghia-Akli, Deputy director-general of DG RTD, European Commission

  • Tore Godal, Special Adviser on Global Health, Section for Global Initiatives, Ministry of Foreign Affairs, Norway

  • Trevor Mundel, President, Global Health Division, The Bill & Melinda Gates Foundation

  • Victor Dzau, President of the Institute of Medicine, National Academy of Sciences

  • Yah Zolia, Deputy Minister of Health and Social Welfare, Liberia

  • Yifru Berhan, Minister of Health, Ethiopia

  • Yusuke Fukuda, Assistant Minister for Technical Affairs and Global Health, Ministry of Health, Labor and Welfare, Japan

 

Observers

  • Marie-Paule Kieny, Assistant Director-General , World Health Organization

  • Mark Feinberg , President and Chief Executive Officer, IAVI (Chair of CEPI Scientific Advisory Committee)

  • Peggy Hamburg, Foreign Secretary of the Institute of Medicine, National Academy of Sciences (Chair of CEPI Joint Coordination Group)

  • John-Arne Røttingen, Interim CEPI CEO

  • George Korch, Acting Assistant Secretary for Preparedness and Response, Department of Health and Human Services, USA (serving in a liaison position)

Interim Board Meetings

First CEPI Interim Board Meeting Documents

The first meeting of the CEPI Interim Board was held in London, 31 August 2016. Here you can download the meeting documents and a summary of the meeting.

ZIP FORMAT - 8KB

Download

First CEPI Interim Board Teleconference

Here you can download a summary of the first CEPI Interim Board teleconference that took place on November 2, 2016.

PDF FORMAT - 356KB

Download

Second CEPI Interim Board Meeting

The second meeting of the CEPI Interim Board was held in New Delhi, 15 - 16 December 2016. Here you can download a summary of the meeting.

PDF FORMAT - 655KB

Download

Second CEPI Interim Board Teleconference

Here you can download a summary of the second CEPI Interim Board teleconference that took place on 12 January 2017.

PDF FORMAT - 512KB

Download

Third CEPI Interim Board Meeting

The third meeting of the CEPI Interim Board was held in Oslo, 27 February 2017. Here you can download a summary of the meeting.

PDF FORMAT - 196KB

Download

Scientific Advisory Committee

  • Mark Feinberg, International AIDS Vaccine Initiative (Chair)
  • Alan D. Barrett, University of Texas Medical Branch
  • Amadou Sall, Institute Pasteur Dakar
  • Bernard Fanget, Abivax, Neovacs
  • Bernadette Murgue, World Health Organization
  • Cherry Gagandeep Kang, Christian Medical College Vellore
  • Connie Schmaljohn, US Army Medical Research Institute of Infectious Diseases
  • Daniel Brasseur, Consultant, former EMA
  • David Kaslow, PATH/CVIA
  • Gary Disbrow, Biomedical Advanced Research and Development Authority
  • George Fu Gao, Chinese Center for Disease Control and Prevention
  • Gunnstein Norheim, Norwegian Institute of Public Health
  • Helen Rees, Wits. Repr. Health and HIV Institute
  • James Robinson, James Robinson Biologics Consulting
  • Jean-François Delfraissy, ANRS/INSERM
  • Jesse Goodman, Georgetown University
  • Kathleeen Neuzil, University of Maryland
  • Kenji Shibuya, Department of Global Health Policy, University of Tokyo
  • Maharaj Kishan Bhan, JIPMER
  • Michael Kurilla, National Institutes of Health
  • Penny Heaton, Bill & Melinda Gates Foundation
  • Peter Smith, London School of Hygiene and Tropical Medicine 
  • Stanley Plotkin, VaxConsult
  • Subhash Kapre, Inventprise

Non-voting members:

  • Ali Alloueche, Takeda
  • Jean Lang, Sanofi Pasteur
  • Johan Van Hoof, Johnson & Johnson
  • Kathrin Jansen, Pfizer

First CEPI SAC meeting

Here you can download a summary of the first CEPI SAC Meeting that was held in New York on October 20-21, 2016.

PDF FORMAT - 762KB

Download

Joint Coordination Group

The first meeting of the CEPI Joint Coordination Group was held in Geneva November 18, 2016 where members of the JCG and invited observers participated. The attending organizations contributed with expertise and experiences in furtherance of fulfilling the CEPI mission by discussing alignment of activities, and making recommendations for how CEPI can best coordinate vaccine development for EID along the ‘end-to-end’ spectrum.

Agenda

PDF FORMAT - 508KB

Download

Summary of proceedings

PDF FORMAT - 946KB

Download

Governing documents

Articles of Association

PDF FORMAT - 302KB

Download

Conflict of interest

PDF FORMAT - 775KB

Download

Delegation of authority

PDF FORMAT - 421KB

Download

Funding Agreements: Key Terms

PDF FORMAT - 305KB

Download

Guidelines for Board members

PDF FORMAT - 306KB

Download

Policy Documentation

1. Equitable access policy

2. Shared risks/shared benefits policy

3. Management of intellectual property

PDF FORMAT - 531KB

Download

Transparency and confidentiality

PDF FORMAT - 313KB

Download

Travel policy

PDF FORMAT - 321KB

Download